Papers
39
Total Citations
2,531
H-Index
22
About
Alon Z. Weizer is a prominent urologic oncologist whose research has profoundly shaped the field of minimally invasive and robotic surgery for urological cancers, particularly bladder cancer and renal tumors. He is perhaps best known as a principal investigator of the landmark RAZOR trial, a randomized phase 3 study comparing robot-assisted to open radical cystectomy in bladder cancer patients, which has garnered over 760 citations since its 2018 publication and established robotic cystectomy as oncologically non-inferior to the traditional open approach. His subsequent three-year follow-up analysis further solidified these findings, influencing surgical decision-making worldwide. Through his leadership within the International Robotic Cystectomy Consortium, Weizer has contributed critical multi-institutional data on urinary diversion techniques and complication profiles following robotic cystectomy. Beyond bladder cancer, his work extends to robotic retroperitoneal lymph node dissection for testicular cancer and minimally invasive partial nephrectomy, including investigations of the RENAL nephrometry scoring system. With a body of work exceeding 1,600 citations across his most impactful studies, Weizer stands as a driving force in advancing evidence-based, minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Matched Comparison of Robotic-assisted and Open Radical Cystectomy111 citations · 2012
- 7
- 8
- 9
- 10